Back to Search
JEREMY BOWEN, PHARMD
PHARMD
Pharmacist
NPI: 1215409966Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Prevention and treatment of regimen-related mucosal toxicity.
PMID 18537748·Recent Pat Anticancer Drug Discov·2008
6-review
Irinotecan changes gene expression in the small intestine of the rat with breast cancer.
PMID 16799812·Cancer Chemother Pharmacol·2007
7-preclinical
Gene expression analysis of multiple gastrointestinal regions reveals activation of common cell regulatory pathways following cytotoxic chemotherapy.
PMID 17594691·Int J Cancer·2007
7-preclinical
VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss.
PMID 17881902·Cancer Biol Ther·2007
7-preclinical
Role of p53 in irinotecan-induced intestinal cell death and mucosal damage.
PMID 17159606·Anticancer Drugs·2007
7-preclinical
Appetite hormones and energy intake in obese men after consumption of fructose, glucose and whey protein beverages.
PMID 17593904·Int J Obes (Lond)·2007
2-rct
Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage.
PMID 16453135·Support Care Cancer·2006
6-review
Appetite regulatory hormone responses to various dietary proteins differ by body mass index status despite similar reductions in ad libitum energy intake.
PMID 16735482·J Clin Endocrinol Metab·2006
4-observational
Energy intake, ghrelin, and cholecystokinin after different carbohydrate and protein preloads in overweight men.
PMID 16434457·J Clin Endocrinol Metab·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3100 CHANNING WAY
IDAHO FALLS, ID 83404 - Phone
- (208) 535-4797
Quick Facts
- NPI
- 1215409966
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile